Cargando…
APOE ε4/ε4 homozygotes with early Alzheimer's disease show accelerated hippocampal atrophy and cortical thinning that correlates with cognitive decline
INTRODUCTION: Hippocampal volume (HV) and cortical thickness are commonly used imaging biomarkers in Alzheimer's disease (AD) trials, and may have utility as selection criteria for enrichment strategies. Atrophy rates of these measures, in the high‐risk apolipoprotein E (APOE) ε4/ε4 homozygous...
Autores principales: | Abushakra, Susan, Porsteinsson, Anton P., Sabbagh, Marwan, Bracoud, Luc, Schaerer, Joel, Power, Aidan, Hey, John A., Scott, David, Suhy, Joyce, Tolar, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7716452/ https://www.ncbi.nlm.nih.gov/pubmed/33304988 http://dx.doi.org/10.1002/trc2.12117 |
Ejemplares similares
-
APOE ε4 Is Associated with Disproportionate Progressive Hippocampal Atrophy in AD
por: Manning, Emily N., et al.
Publicado: (2014) -
White matter microstructure is altered in cognitively normal middle-aged APOE-ε4 homozygotes
por: Operto, Grégory, et al.
Publicado: (2018) -
Polygenic score modifies risk for Alzheimer's disease in APOE ε4 homozygotes at phenotypic extremes
por: Huq, Aamira J., et al.
Publicado: (2021) -
Correction: APOE ε4 Is Associated with Disproportionate Progressive Hippocampal Atrophy in AD
Publicado: (2014) -
Correction: APOE ε4 Is Associated with Disproportionate Progressive Hippocampal Atrophy in AD
Publicado: (2014)